Investigator-initiated randomized controlled trials in infectious diseases: better value for money for registration trials of new antimicrobials

Randomized controlled trials (RCTs) conducted by the industry are expensive, especially trials conducted for registration of new drugs for multidrug-resistant (MDR) bacteria. Lower-cost investigator-initiated trials have recently been successful in recruiting patients with severe infections caused b...

पूर्ण विवरण

ग्रंथसूची विवरण
मुख्य लेखकों: Paul, M, Harbarth, S, Huttner, A, Thwaites, GE, Theuretzbacher, U, Bonten, MJM, Leibovici, L
स्वरूप: Journal article
भाषा:English
प्रकाशित: Oxford University Press 2020

समान संसाधन